Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 269

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype

Open access
Ye, Ting, Deng, Lin, Wang, Shengping, Xiang, Jiaqing, Zhang, Yawei, Hu, Hong, Sun, Yihua, Li, Yuan, Shen, Lei, Xie, Li, Gu, Wenchao, Zhao, Yue, Fu, Fangqiu, Peng, Weijun, Chen, Haiquan·2019·Journal of Thoracic Oncology

Abstract

Introduction: The clinicopathologic features and prognostic predictors of radiological part‐solid lung adenocarcinomas were unclear. Methods: We retrospectively compared the clinicopathologic features and survival times of part‐solid tumors with those of pure ground glass nodules (pGGNs) and pure solid tumors treated with surgery at Fudan University Shanghai Cancer Center and evaluated the prognostic implications of consolidation‐to‐tumor ratio (CTR), solid component size, and tumor size for part‐solid lung adenocarcinomas. Results: A total of 911 patients and 988 pulmonary nodules (including 329 part‐solid nodules [PSNs], 501 pGGNs, and 158 pure solid nodules) were analyzed. More female patients (p = 0.015) and nonsmokers (p = 0.003) were seen with PSNs than with pure solid nodules. The prevalence of lymphatic metastasis was lower in patients with PSNs than in those with pure solid tumors (2.2% versus 27% [p < 0.001]). The 5‐year lung cancer–specific (LCS) recurrence‐free survival and LCS overall survival of patients with PSNs were worse than those of patients with pGGNs (p < 0.001 and p = .042, respectively) but better than those of patients with pure solid tumors ([p < 0.001 and p < 0.0001, respectively]). CTR (OR = 12.90; 95% confidence interval [CI]: 1.85–90.04), solid component size (OR = 1.45; 95% CI: 1.28–1.64), and tumor size (OR = 1.23; 95% CI: 1.15–1.31) could predict pathologic invasive adenocarcinoma for patients with PSNs. None of them could predict the prognosis. Patients receiving sublobar resection had prognoses comparable to those of patients receiving lobectomy (p = .178 for 5‐year LCS recurrence‐free survival and p = .319 for 5‐year LCS overall survival). The prognostic differences between patients with systemic lymph node dissection and those without systemic lymph node dissection were statistically insignificant. Conclusions: Part‐solid lung adenocarcinoma showed clinicopathologic features different from those of pure solid tumor. CTR, solid component size, and tumor size could not predict the prognosis. Part‐solid lung adenocarcinomas define one special clinical subtype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jtho.2018.12.030

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Metadata

Authors
Ye, T., Deng, L., Wang, S., Xiang, J., Zhang, Y., Hu, H., Sun, Y., Li, Y., Shen, L., Xie, L., Gu, W., Zhao, Y., Fu, F., Peng, W., & Chen, H.
Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2019-04
Volume
14
Issue
4
Pages
617-627
ISSN
1556-0864 (ISSN-L)
OpenAlex
W2908887191
Cited by
269
References
19
FWCI
19.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype. https://app.cochat.ai/papers/10.1016/j.jtho.2018.12.030
The paper
Ye, T., Deng, L., Wang, S., Xiang, J., Zhang, Y., Hu, H., Sun, Y., Li, Y., Shen, L., Xie, L., Gu, W., Zhao, Y., Fu, F., Peng, W., & Chen, H. (2019). Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2018.12.030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.